Company News
Pieris Pharmaceuticals appoints Chief Development Officer
Pieris Pharmaceuticals appoints Chief Development Officer
Louis Matis takes up the position at the biotechnology company
Martin Driscoll joins Spring Bank Pharmaceuticals as President and Chief Executive
Martin Driscoll joins Spring Bank Pharmaceuticals as President and Chief Executive
Kurt Eichler is elected to the Board of Directors
Cortex Pharmaceuticals appoints James Manuso as President and CEO
Cortex Pharmaceuticals appoints James Manuso as President and CEO
He also becomes Vice Chairman of the Board of Directors
Medica’s new appointment highlights its healthcare focus
Medica’s new appointment highlights its healthcare focus
Nick Geary joins the business development team to expand the company's pharma customer base
Eiger BioPharmaceuticals adds two to senior management team
Eiger BioPharmaceuticals adds two to senior management team
Jim Welch joins as Chief Financial Officer and Jim Shaffer as Chief Business Officer
Ocean Optics hires Service and Operations Manager for its EMEA office
Ocean Optics hires Service and Operations Manager for its EMEA office
Zimon Norlin to lead manufacturing, service and logistics in Europe, Middle East and Africa
Scott Plesha joins BioDelivery Sciences as Senior Vice President of Sales
Scott Plesha joins BioDelivery Sciences as Senior Vice President of Sales
He brings more than 25 years of sales experience to the company
Sutro Biopharma appoints Vice President of Alliance and Project Management
Sutro Biopharma appoints Vice President of Alliance and Project Management
Nicki Vasquez brings expertise in management of preclinical and clinical therapeutic development to the firm
Anand Varadan joins Chiasma as Chief Commercial Officer
Anand Varadan joins Chiasma as Chief Commercial Officer
Takes responsibility for commercial activities in the US and Europe around launch of oral octreotide capsules
Wickham Laboratories announces appointment of CEO
Wickham Laboratories announces appointment of CEO
Appointment of John McKenzie PhD, FRSC in the role of Chief Executive Officer as part of a long term strategy for corporate growth and development
Mocon announces new VP of Engineering and Manufacturing
Mocon announces new VP of Engineering and Manufacturing
Michael Barto joins the US instrumentation and testing firm
APCER Life Sciences appoints Dr Sutinder Bindra as Global Head of Medical Affairs
APCER Life Sciences appoints Dr Sutinder Bindra as Global Head of Medical Affairs
Continues to build its globally integrated capabilities by opening a Hong Kong office
Catalent Biologics announces new advisory board
Catalent Biologics announces new advisory board
It has diverse expertise in biologics development and commercialisation
New generation takes over at Romaco Innojet
New generation takes over at Romaco Innojet
Zeljko Pockaj becomes Managing Director
Bionomics strengthens management team
Bionomics strengthens management team
Appoints Tony Colasin as US-based Chief Business Officer
Quotient Clinical’s Chief Scientific Officer awarded honorary professorship at the University of Nottingham
Quotient Clinical’s Chief Scientific Officer awarded honorary professorship at the University of Nottingham
Dr Peter Scholes spent six years studying at the University
Dr Jan Wren joins SafeBridge Europe
Dr Jan Wren joins SafeBridge Europe
Brings more than 20 years' experience at GSK to the position
Brian Hilberdink promoted to President of Novo Nordisk Canada
Brian Hilberdink promoted to President of Novo Nordisk Canada
He has been with the Denmark-headquartered insulin specialist for 20 years
Bruce Seeley joins CTI BioPharma as EVP and Chief Commercial Officer
Bruce Seeley joins CTI BioPharma as EVP and Chief Commercial Officer
Brings more than 25 years of relevant experience to the position
Intrexon adds three to executive team
Intrexon adds three to executive team
In Communications, Finance and Head of the Health Sector
Baxalta appoints Jacopo Leonardi as EVP and President Immunology
Baxalta appoints Jacopo Leonardi as EVP and President Immunology
Biopharmaceutical firm specialises in developing and manufacturing plasma-based therapies for rare diseases
Novogen appoints Iain Ross as acting CEO
Novogen appoints Iain Ross as acting CEO
Dr Graham Kelly has decided to leave the company to resume non-oncology based early stage research
BioClinica expands eClinical leadership team
BioClinica expands eClinical leadership team
Andrew Masters and Angelo Stortini take key roles in the eClinical solutions team
Richard Torbett to join ABPI
Richard Torbett to join ABPI
To lead the commercial team as Executive Director – Commercial UK